E
Mesoblast Limited
MESO
$11.82
-$0.08-0.67%
E
Sell
3/14/2023Downgrade
Mesoblast Limited (MESO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
Mesoblast Limited (MESO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
D
Sell
2/28/2023Downgrade
Mesoblast Limited (MESO) was downgraded to D- from D on 2/28/2023 due to a decline in the growth index and solvency index. Earnings per share declined from -$0.0243 to -$0.0332, the quick ratio declined from 1.82 to 1.31, and EBIT declined 23.89% from -$16.01M to -$19.83M.
Mesoblast Limited (MESO) was downgraded to D- from D on 2/28/2023 due to a decline in the growth index and solvency index. Earnings per share declined from -$0.0243 to -$0.0332, the quick ratio declined from 1.82 to 1.31, and EBIT declined 23.89% from -$16.01M to -$19.83M.
D
Sell
2/9/2023Upgraded
Mesoblast Limited (MESO) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index.
Mesoblast Limited (MESO) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
Mesoblast Limited (MESO) was downgraded to E+ from D on 2/8/2023 due to a decline in the growth index and valuation index. Total revenue declined 32.39% from $2.22M to $1.5M, and operating cash flow declined 2.83% from -$13.89M to -$14.29M.
Mesoblast Limited (MESO) was downgraded to E+ from D on 2/8/2023 due to a decline in the growth index and valuation index. Total revenue declined 32.39% from $2.22M to $1.5M, and operating cash flow declined 2.83% from -$13.89M to -$14.29M.
D
Sell
6/2/2022Upgraded
Mesoblast Limited (MESO) was upgraded to D from D- on 6/2/2022 due to a large increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.04 to -$0.0328, EBIT increased 12.96% from -$22.22M to -$19.34M, and operating cash flow increased 7.98% from -$16.81M to -$15.47M.
Mesoblast Limited (MESO) was upgraded to D from D- on 6/2/2022 due to a large increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.04 to -$0.0328, EBIT increased 12.96% from -$22.22M to -$19.34M, and operating cash flow increased 7.98% from -$16.81M to -$15.47M.
D
Sell
5/5/2022Upgraded
Mesoblast Limited (MESO) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index and growth index.
Mesoblast Limited (MESO) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index and growth index.
E
Sell
4/20/2022Downgrade
Mesoblast Limited (MESO) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
Mesoblast Limited (MESO) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
3/25/2022Downgrade
Mesoblast Limited (MESO) was downgraded to D- from D on 3/25/2022 due to a decline in the total return index, solvency index and volatility index.
Mesoblast Limited (MESO) was downgraded to D- from D on 3/25/2022 due to a decline in the total return index, solvency index and volatility index.
D
Sell
1/13/2022Upgraded
Mesoblast Limited (MESO) was upgraded to D from D- on 1/13/2022 due to an increase in the total return index.
Mesoblast Limited (MESO) was upgraded to D from D- on 1/13/2022 due to an increase in the total return index.
D
Sell
12/29/2021Downgrade
Mesoblast Limited (MESO) was downgraded to D- from D on 12/29/2021 due to a decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.0341 to -$0.0349.
Mesoblast Limited (MESO) was downgraded to D- from D on 12/29/2021 due to a decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.0341 to -$0.0349.
D
Sell
11/9/2021Upgraded
Mesoblast Limited (MESO) was upgraded to D from E+ on 11/09/2021.
Mesoblast Limited (MESO) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Mesoblast Limited (MESO) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the growth index, efficiency index and valuation index. Total capital declined 2.26% from $702.77M to $686.89M.
Mesoblast Limited (MESO) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the growth index, efficiency index and valuation index. Total capital declined 2.26% from $702.77M to $686.89M.
D
Sell
1/10/2019Downgrade
Mesoblast Limited (MESO) was downgraded to D from D+ on 1/10/2019 due to a decline in the total return index and volatility index.
Mesoblast Limited (MESO) was downgraded to D from D+ on 1/10/2019 due to a decline in the total return index and volatility index.
D
Sell
11/19/2018Upgraded
Mesoblast Limited (MESO) was upgraded to D+ from D on 11/19/2018 due to a noticeable increase in the growth index. Total revenue increased 584.53% from $1.7M to $11.64M, EBIT increased 26.39% from -$22.8M to -$16.78M, and earnings per share increased from -$0.044 to -$0.0407.
Mesoblast Limited (MESO) was upgraded to D+ from D on 11/19/2018 due to a noticeable increase in the growth index. Total revenue increased 584.53% from $1.7M to $11.64M, EBIT increased 26.39% from -$22.8M to -$16.78M, and earnings per share increased from -$0.044 to -$0.0407.
D
Sell
10/30/2018Downgrade
Mesoblast Limited (MESO) was downgraded to D from D+ on 10/30/2018 due to a decline in the volatility index.
Mesoblast Limited (MESO) was downgraded to D from D+ on 10/30/2018 due to a decline in the volatility index.
D
Sell
10/15/2018Upgraded
Mesoblast Limited (MESO) was upgraded to D+ from D on 10/15/2018 due to a major increase in the total return index, growth index and volatility index. Total revenue increased 58.88% from $1.07M to $1.7M, EBIT increased 3.41% from -$23.61M to -$22.8M, and earnings per share increased from -$0.0447 to -$0.044.
Mesoblast Limited (MESO) was upgraded to D+ from D on 10/15/2018 due to a major increase in the total return index, growth index and volatility index. Total revenue increased 58.88% from $1.07M to $1.7M, EBIT increased 3.41% from -$23.61M to -$22.8M, and earnings per share increased from -$0.0447 to -$0.044.
D
Sell
2/28/2018Upgraded
Mesoblast Limited (MESO) was upgraded to D from D- on 2/28/2018 due to a noticeable increase in the growth index, efficiency index and solvency index. Total revenue increased 1,041.14% from $1.17M to $13.4M, net income increased 295.14% from -$7.02M to $13.7M, and earnings per share increased from -$0.016 to $0.0291.
Mesoblast Limited (MESO) was upgraded to D from D- on 2/28/2018 due to a noticeable increase in the growth index, efficiency index and solvency index. Total revenue increased 1,041.14% from $1.17M to $13.4M, net income increased 295.14% from -$7.02M to $13.7M, and earnings per share increased from -$0.016 to $0.0291.
D
Sell
2/26/2018Downgrade
Mesoblast Limited (MESO) was downgraded to D- from D on 2/26/2018 due to a significant decline in the growth index, total return index and volatility index.
Mesoblast Limited (MESO) was downgraded to D- from D on 2/26/2018 due to a significant decline in the growth index, total return index and volatility index.
D
Sell
8/22/2017Downgrade
Mesoblast Limited (MESO) was downgraded to D from D+ on 8/22/2017 due to a decline in the volatility index.
Mesoblast Limited (MESO) was downgraded to D from D+ on 8/22/2017 due to a decline in the volatility index.
D
Sell
5/26/2017Upgraded
Mesoblast Limited (MESO) was upgraded to D+ from D on 5/26/2017 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 63.82% from $550 to $901, earnings per share increased from -$0.0527 to -$0.0246, and EBIT increased 3.77% from -$22.85M to -$21.98M.
Mesoblast Limited (MESO) was upgraded to D+ from D on 5/26/2017 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 63.82% from $550 to $901, earnings per share increased from -$0.0527 to -$0.0246, and EBIT increased 3.77% from -$22.85M to -$21.98M.
D
Sell
5/12/2016Upgraded
Mesoblast Limited (MESO) was upgraded to D from D- on 5/12/2016 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.3145 to -$0.2245, total revenue increased 3.19% from $4.01M to $4.14M, and EBIT increased 2.19% from -$20.83M to -$20.38M.
Mesoblast Limited (MESO) was upgraded to D from D- on 5/12/2016 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.3145 to -$0.2245, total revenue increased 3.19% from $4.01M to $4.14M, and EBIT increased 2.19% from -$20.83M to -$20.38M.
D
Sell
3/11/2016Downgrade
Mesoblast Limited (MESO) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and efficiency index.
Mesoblast Limited (MESO) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and efficiency index.
D
Sell
2/17/2016Downgrade
Mesoblast Limited (MESO) was downgraded to D from D+ on 2/17/2016 due to a substantial decline in the growth index, efficiency index and volatility index. Total revenue declined 46.57% from $7.51M to $4.01M, and operating cash flow declined 29.43% from -$28.07M to -$19.81M.
Mesoblast Limited (MESO) was downgraded to D from D+ on 2/17/2016 due to a substantial decline in the growth index, efficiency index and volatility index. Total revenue declined 46.57% from $7.51M to $4.01M, and operating cash flow declined 29.43% from -$28.07M to -$19.81M.
D
Sell
1/15/2016Downgrade
Mesoblast Limited (MESO) was downgraded to D+ from C- on 1/15/2016 due to a large decline in the total return index.
Mesoblast Limited (MESO) was downgraded to D+ from C- on 1/15/2016 due to a large decline in the total return index.
C
Hold
12/31/2015Upgraded
Mesoblast Limited (MESO) was upgraded to C- from D+ on 12/31/2015 due to a large increase in the growth index and total return index.
Mesoblast Limited (MESO) was upgraded to C- from D+ on 12/31/2015 due to a large increase in the growth index and total return index.
D
Sell
12/28/2015Upgraded
Mesoblast Limited (MESO) was upgraded to D+ from D on 12/28/2015 due to a noticeable increase in the growth index, total return index and efficiency index. Earnings per share increased from -$0.411 to -$19.7, total revenue increased 46.9% from $5.11M to $7.51M, and operating cash flow increased 10.68% from -$25.36M to -$28.07M.
Mesoblast Limited (MESO) was upgraded to D+ from D on 12/28/2015 due to a noticeable increase in the growth index, total return index and efficiency index. Earnings per share increased from -$0.411 to -$19.7, total revenue increased 46.9% from $5.11M to $7.51M, and operating cash flow increased 10.68% from -$25.36M to -$28.07M.
D
Sell
12/4/2015None
Mesoblast Limited (MESO) was downgraded to D from U on 12/04/2015.
Mesoblast Limited (MESO) was downgraded to D from U on 12/04/2015.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
